拜耳·亦庄开放创新中心正式启用

Core Viewpoint - Bayer's YiZhuang Open Innovation Center in Beijing aims to integrate industry, education, research, and entrepreneurship, linking "Chinese innovation" with "global wisdom" as part of its strategy in China [1][3]. Group 1: Innovation Center Launch - The YiZhuang Open Innovation Center is Bayer's first innovation center in China, located in the International Pharmaceutical Innovation Park (BioPark) [3]. - The center will incubate local innovative pharmaceutical companies and enhance the global competitiveness of Chinese innovations [3][5]. - Bayer's commitment to local innovation is reinforced by partnerships with top academic institutions like Tsinghua University and Peking University, focusing on transforming cutting-edge research into new drugs [5][12]. Group 2: Collaboration and Ecosystem - Bayer Co.Lab, a global life sciences co-creation platform, will also be established in Beijing, working alongside the YiZhuang Open Innovation Center to deepen local innovation collaboration [7]. - The first companies to join Bayer Co.Lab include Puhe Pharma, which focuses on innovative small molecule therapies, and Yaojing Gene, specializing in gene therapy [8][14][15]. - The center will facilitate the transformation of early-stage innovations and support the internationalization of local biotech startups [7][10]. Group 3: Events and Partnerships - A series of events, including the "China-Europe Sci-Tech Innovation Community Theme Day," will be held at the new center, promoting dialogue between top scientists and industry leaders from both regions [10]. - Bayer has conducted over 100 joint research projects with Chinese universities over the past decade, establishing itself as a key player in the local biotech landscape [12]. - Bayer's Beijing factory is the largest prescription drug packaging base globally, highlighting its significant investment and operational scale in China [12].